Saturday, July 11, 2026

Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO

Oct 5, 2021

Click the Subscribe button for the latest in crypto, blockchain and business news from NEW TO THE STREET!

See the full episode at: https://newtothestreet.com/new-to-the-street-241-october-3rd-2021-hapbee-technologies-tonix-pharmaceuticals-first-wave-biopharma-globex-data-strikeforce-technologies-kylin-network-sekur

#crypto #cryptocurrency #blockquake #blockchain #blockchainnews #digitalcurrency #newtothestreet #janeking #exploringtheblock #foxbusinessnews #foxbusiness #financialnews #businessnews #ai #newsmaxtv #TonixPharmaceuticals

Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) CEO, Seth Lederman, talks to “New To The Street” TV with Host, Jane King, in-studio at NASDAQ. The Company recently received FDA guidance on its TNX-1800, Mr. Lederman explains the significance of this guidance. Recently, the Company entered into a collaboration with Columbia University in New York City, a scientific relationship that focuses on the COVID-19 immune responses by both people who recovered from COVID and those who were asymptomatic to the virus. Seth explains the differences between a live virus vaccine, which TNXP has in development, and the mRNA vaccines currently being offered worldwide. He explains that the TNX -1800, a live vaccine, has shown it disables the virus, limits forward transmissions and can be a cheaper vaccine to deploy. Additionally, Seth talks about the need for oral anti-viral pharmaceuticals for the treatment of those infected with COVID-19, and he sees that the combination of the TNXP’s oral product with Remdesivir have shown strong clinical test results. Before conclusion of the interview, Seth explains the unique relationship with himself, the Company and Columbia University, and he remains excited on the scientific outcomes on the recently announce collaborations and them working together with the science of in vitro T-cells for the future of vaccines.

To make sure you never miss a video from New to the Street, click here to subscribe: https://www.youtube.com/channel/UCceRKKS0QUfXlKUPBoxdTHQ

Follow New to the Street on Twitter: https://twitter.com/NewToTheStreet
Follow New to the Street on Facebook: https://www.facebook.com/newtothestreet/
Follow New to the Street on Instagram: https://www.instagram.com/newtothestreettv/
Follow New to the Street on Rumble: https://rumble.com/user/newtothestreet
About New to the Street: https://newtothestreet.com/

Subscribe to our Mailing List: https://mailchi.mp/ccd21b3e3fab/join-our-mailing-list